Thick Skin Rhinoplasty: Managing Swelling, Fibrosis and Scar Tissue After Surgery

Dr Scott J Turner | Specialist Plastic Surgeon (FRACS) | Sydney

Thick skin changes how the nose settles after rhinoplasty. The soft tissue envelope holds swelling for longer, and in some patients it forms firmer scar tissue over the supratip or tip. A refined result is still possible. It just means the surgical and postoperative plans need to work together with more deliberate steps.

Most of the questions I get from patients with thicker skin are about the same area. The bridge feels fine. The tip looks fuller than expected. Six months in, things still don’t feel quite settled. Sometimes that is normal swelling running its course. Other times it is something firmer that benefits from targeted treatment.

This article focuses on what happens after surgery. Specifically, the role of close follow-up during the first year, and how decisions about Kenacort-A 10 or 5-FU injections are made within that cadence at my rhinoplasty consultations in Bondi Junction and Manly. For the pre-surgical picture of how thick skin influences surgical planning, my earlier blog on thick skin rhinoplasty challenges and solutions covers that side. I’m a Specialist Plastic Surgeon (FRACS) and I see patients for primary and revision rhinoplasty at both Sydney clinics.

How thick skin shapes recovery

Thin skin reveals contour changes quickly, but it can also show small irregularities. Thick skin works the other way. It camouflages minor surface differences, but it takes longer to contract. Slower to settle. Slower to reveal the underlying shape.

The supratip is the area just above the nasal tip, where fullness tends to linger in thick-skinned patients. If swelling or scar tissue holds in this area, the nose can look fuller than expected. In some cases that fullness develops into what surgeons call a pollybeak appearance, where the supratip sits higher than the tip itself.

A prospective study using ultrasound found that thick-skinned patients who didn’t receive targeted treatment tended to develop measurable thickening at several nasal sites postoperatively, while patients who received triamcinolone injections at planned intervals showed thinning at the supratip and tip by around six weeks (Aydın et al., Laryngoscope Investigative Otolaryngology). The takeaway isn’t that everyone needs injections. It’s that thick skin doesn’t always reshape itself, and waiting can lock in the swelling rather than resolve it.

The first year of follow-up: what it looks like

For thick-skinned patients, the postoperative review schedule is closer-spaced than for thin-skinned patients. Thick skin doesn’t tell you what it’s doing on a wide review interval. The tissue needs to be seen often enough to catch firmer changes while they are still soft enough to respond to non-surgical treatment.

Weeks 1 to 6: protected healing phase. Tape and splint are managed, swelling is at its peak. The tissue is too reactive for any injection, and most of what looks like fullness is fluid that will move on its own. Follow-up here is about monitoring healing and taping.

Weeks 6 to 8: assessment window opens. By week 6 the tissues are stable enough to assess properly. Soft swelling is starting to differentiate from anything firmer underneath. If early supratip fullness feels soft and inflammatory, this is the earliest point a small steroid injection might be considered.

Months 3 to 6: most active management phase. This is where most targeted intervention happens, if it’s going to. Residual swelling has resolved enough that anything still sitting in the supratip is more meaningful. Soft persistent swelling may benefit from steroid; firmer tissue may warrant adding 5-FU to the mix.

Months 6 to 12: refinement and reassessment. By 6 months the picture is clearer. Many patients are settling well. Thicker skin or revision cases may need closer monitoring. This is also when structural problems start to declare themselves separately from soft tissue. If cartilage support isn’t holding shape, no injection will solve that, and the conversation may shift toward revision.

12 months and beyond. Most patients have a settled or near-settled result. Refinement may continue up to 18 months. Annual review focuses on long-term stability.

Example schedule and injection cadence

The cadence below is illustrative, not a fixed protocol. Any decision to use injections is examination-based.

Typical total across the year, for patients who need injections: 2 to 4 sessions. Thicker skin, revision cases or persistent fibrosis may extend this to 4 to 6 sessions over 12 months. Many patients need no injections, which is a good outcome.

What this asks of both sides

Thick-skin rhinoplasty is one of the more demanding postoperative journeys, not because recovery is harder but because the work doesn’t end when surgery does. The result at twelve months reflects what happened in the operating theatre. It also reflects the months of close follow-up, the taping that did or didn’t get done properly, and the decisions made at each review.

What I’m asking of my thick-skinned patients is real engagement with the postoperative process. Showing up for reviews even when nothing feels wrong. Persisting with taping and massage. Telling me about subtle changes at the tip rather than waiting until something is obviously off. Accepting that the timeline runs longer than you might want.

What you can expect in return is matching commitment. Closer review intervals when the tissue is unsettled. A clear plan at each review, not vague reassurance. Honest conversations when an injection isn’t needed, as well as when it is. Availability across the full year, not just the early weeks.

The procedure is one day. The commitment runs for a year, on both sides.

Oedema versus fibrosis: not the same thing

When a patient sits in front of me with persistent supratip fullness, the first thing I’m trying to work out is what kind of fullness it is.

Oedema is the soft, fluid-like swelling we expect early after surgery. It compresses. It moves a little. It tends to be worse in the morning and after warm showers.

Fibrosis is different. It feels firmer, more organised, less compressible. It’s soft tissue laying down extra collagen as part of healing, and in thick skin that response can be more pronounced. Sometimes it settles on its own. Sometimes it doesn’t.

Why does the distinction matter? Because the treatments target different things. Steroid injections like Kenacort-A 10 calm inflammation and reduce oedema. They are not anti-scar treatments. 5-FU works on scar tissue by reducing fibroblast activity, the cells that produce collagen. Two different problems. Two different tools.

Kenacort-A 10: the anti-inflammatory option

Kenacort-A 10 is a corticosteroid preparation of triamcinolone at 10 mg per mL. It has the longest track record in post-rhinoplasty injection management, and the most published rhinoplasty-specific evidence behind it.

A 2025 systematic review found that triamcinolone injections after rhinoplasty were associated with reduced postoperative oedema and lower rates of pollybeak deformity. The protocols described in the literature commonly use 10 mg/mL concentration, start no earlier than around four weeks after surgery, and run at four to six week intervals using small volumes (Villarroel et al., Thieme).

The strength of Kenacort is its predictability for soft swelling. The downside is what can happen with overuse. Repeated or excessive steroid injection can cause skin thinning, loss of underlying soft tissue volume, small surface blood vessels and pigment changes. These risks are higher in patients with thinner skin in surrounding areas, in revision cases, and in any tissue that is already delicate.

My approach is conservative. The aim is never to aggressively shrink swelling. It’s to calm inflammation just enough to support natural settling, while protecting long-term skin quality.

5-FU: when scar tissue is the problem

5-FU stands for 5-fluorouracil. It’s an antimetabolite that has been used in dermatology and scar management for decades because it can inhibit fibroblast activity and reduce collagen production. In simple terms, it works on scar tissue rather than swelling.

In rhinoplasty, 5-FU sits in a more specialised role. It’s considered when the postoperative problem looks more fibrotic than oedematous. Dense supratip fibrosis. Stiff scar tissue that hasn’t responded to taping or time. Revision rhinoplasty with thickened soft tissue. Thick sebaceous skin laying down firm tissue rather than soft swelling.

Some surgeons combine a small amount of steroid with 5-FU. The idea is to keep an anti-inflammatory effect in the mix while limiting how much steroid the tissue is exposed to. A network meta-analysis of hypertrophic scar and keloid treatments outside of rhinoplasty reported that triamcinolone combined with 5-FU improved efficacy compared with triamcinolone alone, and reduced steroid-related adverse effects (Yang et al., Frontiers in Medicine). The rhinoplasty-specific evidence for 5-FU is less standardised than for steroid alone, but published nasal-region protocols describe 5-FU with low-dose triamcinolone in carefully selected fibrosis cases, using very small per-session volumes (Blugerman et al., IntechOpen).

Timing, dose and intervals: the principles

Specific dosing is always tailored to the patient and examination findings rather than a fixed recipe. A few principles cut across both steroid and 5-FU treatment.

For fibrotic tissue, the timing tends to be later than for soft swelling, and the treatment is more about persistence than dose. Small volumes. Serial sessions. Reassessment between treatments rather than treating on a fixed schedule. If the tissue is softening, additional sessions may not be needed. If it isn’t responding, the plan changes.

The principle across both approaches is the same. Diagnose first. Treat conservatively. Reassess often. Stop when the response is enough.

Why conservative dosing matters

Both Kenacort and 5-FU can change the way soft tissue behaves. Used carefully, they can help selected patients avoid prolonged fullness or scar thickening that may not resolve on its own. Used too aggressively, they can cause thinning of the skin, visible contour irregularity, or surface blood vessels that weren’t there before. Over-correction is another problem they can create, and it can be harder to reverse than the original fullness.

This is why I don’t treat injections as a default postoperative tool. They are a considered option in specific situations, not a routine add-on. Soft swelling, firm fibrosis and structural problems can all look similar in the mirror; the treatment for each is different.

For thick skin specifically, the soft tissue envelope is more forgiving of measured intervention but also more vulnerable to over-correction. Conservative steps with reassessment in between give the tissue room to settle without locking in an over-treated result.

What this means if you have had rhinoplasty

If you’ve had rhinoplasty and you’re noticing persistent supratip fullness, firm scar tissue, or a change in contour that wasn’t there at six weeks, it’s worth being assessed. Some swelling is normal and resolves with time, massage and taping. Some patterns benefit from targeted injection. Some are structural and won’t respond to non-surgical treatment regardless of how many sessions are tried.

I see patients for primary and revision rhinoplasty at my Sydney rhinoplasty practice, including tip rhinoplasty and ethnic rhinoplasty. If you’re not sure whether what you are seeing is normal healing or something that needs intervention, a review is the right starting point. You can contact the rooms here to arrange one.

All surgery carries risks and outcomes vary between individuals. Any decision about post-rhinoplasty injection should be made after consultation with your surgeon.

Frequently asked questions

How often will I be reviewed in the first year after thick skin rhinoplasty?

Thick-skinned patients are seen on a closer follow-up schedule than thin-skinned patients during the first year. After the initial healing phase, reviews are most commonly every 4 to 6 weeks between months 3 and 6, then spaced out as the tissue settles. The aim is to catch firm changes early, while they are still soft enough to respond to non-surgical treatment, rather than waiting until something has organised into stiffer scar tissue.

Are 5-FU injections safe to use after rhinoplasty?

5-FU has been used for scar management in medical practice for many years, and there is published experience with its use in selected post-rhinoplasty cases. That said, it is only suitable in specific situations and should only be administered by an appropriately trained clinician after examination. It is not a routine post-rhinoplasty treatment, and it is reserved for clear fibrotic findings rather than soft swelling.

Can taping alone manage swelling and fibrosis?

Taping can help in the early postoperative period and is part of most rhinoplasty recovery plans. For soft oedema, taping combined with time often does the job. For firmer fibrosis that hasn’t responded to taping, additional treatment may be considered. Whether injection is the right next step depends on the examination findings, not on the calendar.

Will steroid injections thin the skin on my nose?

Repeated or high-dose steroid injection can cause skin thinning, loss of underlying volume and visible contour change. This is why dosing matters. Small volumes, appropriate concentration, spaced intervals and stopping treatment once a response is achieved all reduce that risk. Patients at highest risk are those with thinner skin in surrounding areas, revision cases, and any tissue with reduced reserve to begin with.

What if my supratip fullness is structural rather than swelling?

This is an important question, and one I check for at every review. If the underlying cartilage support is insufficient, no amount of injection will fix the contour. Structural causes need a structural solution, which usually means revision surgery. The point of assessment is to separate problems that respond to non-surgical treatment from those that don’t, so you aren’t spending time and money on injections that were never going to address the root cause.